Summary
Bone marrow transplantation is the treatment of choice of many haematological disorders but its success is limited by two major complications, graft-versus-host disease (GVHD) and pulmonary disorders. Of the first 31 patients transplanted at St. James’s Hospital (1984–1986) 16 (52%) had a successful outcome. Of the 15 patients who died, two died of GVHD and one of recurrent leukaemia. All others had severe pulmonary disease either causing death directly (9 cases) or contributing to death from toxic encephalopathy, carditis or recurrent leukaemia (1 case each). The principal forms of pulmonary disease were cytomegalovirus pneumonitis (4 cases), acute haemorrhagic pulmonary oedema (4 cases) and Pneumocystis carinii pneumonia (2 cases). There were single cases of staphylococcal pneumonia and idiopathic pulmonary fibrosis. Aspergillus was a second pathogen in two cases. Pulmonary damage due to conditioning chemoradiotherapy and to GVHD probably underlies this high incidence of pulmonary disease. T-cell depletion to limit the incidence of GVHD together with increased prophylaxis against CMV and Pneumocystis carinii will probably substantially reduce these complications in the near future.
Similar content being viewed by others
References
Bortin, M. M., Gale, R. P., Kay, H. E. M., Rimm, A. A. Bone Marrow transplantation for acute myelogenous leukaemia: Factors associated with early mortality. JAMA 1986; 249: 1166–75.
Gale, R. P., Kersey, J. H., Bortin, M. M. et al. Bone marrow transplantations for acute lymphoblastic leukaemia. Lancet 1983; 2: 663–67.
Speck, B., Bortin, M. M., Champlin, R. et al. Allogeneic bone marrow transplantation for chronic myelogenous leukaemia. Lancet 1984; 1: 665–668.
Bortin, M. M., Gale, R. P., Rimm, A. A. Allogeneic bone marrow transplantation for 144 pateints with severe aplastic anaemia. JAMA 1981; 245: 1132–39.
Bortin, M. M., Rimm, A. A. Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation. JAMA 1977; 238: 591–600.
Santos, G. W. Bone marrow transplantation in leukaemia: Current status. Cancer 1984; 54: 2732–2740.
Krowka, M. J., Rosenow, E. Pulmonary complication of bone marrow transplantation. Chest 1985: 87: 2 237–245.
Buckner, C. D., Meyers, J. D., Springmeyer, S. C. et al. Pulmonary complications of marrow transplantation; Review of Seattle experience. Exp Haematol 1984; 12 (suppl. 15) 1–5.
Weiner, R. S., Bortin, M. M., Gale, R. P., Gluckman, E. et al. Interstinal pneumonitis following bone marrow transplantation: Assessment of risk factors. Annals of Int Medicine 1986; 174: 2 168–174.
Watson, J. G. Problems of infection after bone marrow transplantation. J Clin Path 1983; 36, 6: 683–692.
MacNamara, E., Clarke, S., McCann, S. R. Provision of leucocyte poor blood at the bedside. J. Clin Path 1984; 37: 669–672.
Bambi, J. A., Cardesa, A., Liebania, C., Rives, A., Carreras, A., Graflena, A., Jimenez de Anta M.T. Main autopsy findings in bone marrow transplant patients. Arch Pathol Lab Med 1987: 111: 125–129.
Sloane, J. P., Depledge, M. H., Powles, R. L., Morgenstem, G. R., Trickey, B. S., Dady, P. J. Histopathology of the lung after bone marrow transplantation. J Clin Path 1983; 36: 546–554.
Murray, M., Teahan, C., Prichard, J., McCann, S. R. Pulmonary function post-allogeneic bone marrow transplantation. Bone Marrow Transplantation 1986; vol 1, suppl 1: 212.
Meyers, J. D., Floumey, N., Wade, J. G, Hackman, R. G., McDougall, J. K., Neiman, P. E., Thomas, E. D. Bioplogy of interstitial pneumonia after marrow transplantation. In: Gale, R. P., Ed. Recent advances in bone marrow transplantation. New York: Alan R. Liss Inc 1983: 425–444.
Keane, T. J., Van Dyk, J., Rider, W. D. Idiopathic interstitial pneumonia following bone marrow transplantaion: The relationship with total body irradiation. Int J Radiat Oncol Biol Phys l981; 7: 1365.
Collis, C. H. Lung damage after cytotoxic drugs. Cancer Chemotherapy and Pharmacology 1980; 17–27.
Sostman, H. D., Mattay, R. A., Putman, C. E. Cytoxic drug-induced lung disease. A, J Med 1977; 62 608–615.
Santos, G. W., Tutsch, P. J., Brookmeyer, R., et al. Marrow transplantation for acute nonlymphocytic leukaemia after treatment with Busulfan and Cyclophosphamide. New Engl J Med 1983; 309: 1347–1353.
Winston, D. J., Ho, W. G., Champlin, R. E., Gale, R. P. Treatment and prevention of interstitial pneumonia associated with bone marrow trannsplantion. In... Gale, R. P., Ed. Recent advances in bone marrow transplantation. New York Alan R Liss Inc 1983: 425–444.
Miller, W., Flynn, P., McCullough, J. et al. Cytomegalovirus infection after bone marrow transpolantation: An association with acute graft v host disease. Blood 1986; 67, 4: 1162–1167.
Yeager, A. S., Grumet, F. C., Hafleigh, E. B. et al. Prevention of transfusion acquired cytomegalovirus infection in newborn infants. J Pediatr 1981; 98: 281.
Winston, D. J., Winston, G. H., Lin, C. H. et al. Intravenous immune globulin for prevention of cytomegalovirus and interstitial pneumonia after bone marrow transplantation. Annals of Internal Medicine 1987; 106: 12–18.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murray, M., O’Briain, D.S., Prichard, J. et al. Pulmonary disease following allogeneic bone marrow transplantation. I.J.M.S. 158, 36–39 (1989). https://doi.org/10.1007/BF02942059
Issue Date:
DOI: https://doi.org/10.1007/BF02942059